| DC Field | Value | Language |
|---|
| dc.contributor.author | Alehin, S. A. | - |
| dc.contributor.author | Kolmykov, D. I. | - |
| dc.contributor.author | Pokrovskii, M. V. | - |
| dc.date.accessioned | 2022-05-02T12:36:28Z | - |
| dc.date.available | 2022-05-02T12:36:28Z | - |
| dc.date.issued | 2015 | - |
| dc.identifier.citation | Alehin, S.A. Human recombinant erythropoietin gradient dosage influence on ischemic and reperfusion liver injury / S.A. Alehin, D.I. Kolmykov, M.V. Pokrovskii // Research Result: Pharmacology and Clinical Pharmacology. - 2015. - Vol. 1, № 1(1).- P. 9-12. - Doi: 10.18413/2500-235X-2015-1-4-9-14. - Refer.: p. 12. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46546 | - |
| dc.description.abstract | We investigate influence of human recombinant erythropoietin different dosage on blood flow velocity and morphological changes in liver during ischemic and reperfusion injury. It was proved what optimal preconditioning dosage is 50 IU/kg | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | human recombinant erythropoietin | ru |
| dc.subject | ischemia | ru |
| dc.subject | reperfusion | ru |
| dc.subject | liver | ru |
| dc.subject | blood flow | ru |
| dc.subject | morphological changes | ru |
| dc.title | Human recombinant erythropoietin gradient dosage influence on ischemic and reperfusion liver injury | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 1, № 1
|
